Skip to main navigation Skip to search Skip to main content

Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)

  • Jean Booth
  • , Tim Clayton
  • , John Pepper
  • , Fiona Nugara
  • , Marcus Flather
  • , Ulrich Sigwart
  • , Rodney H Stables
  • , SoS Investigators

Research output: Contribution to journalArticlepeer-review

194 Citations (Scopus)

Abstract

The Stent or Surgery Trial is a randomized, controlled trial comparing percutaneous coronary intervention with coronary artery bypass grafting (CABG) for patients with multivessel disease. Initial results at a median follow-up of 2 years showed a survival advantage for patients randomized to CABG. This article reports survival outcome at a median follow-up of 6 years.
Original languageEnglish
Pages (from-to)381-8
Number of pages8
JournalCirculation
Volume118
Issue number4
DOIs
Publication statusPublished - 22 Jul 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aged
  • Angina Pectoris
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Bypass
  • Coronary Artery Disease
  • Diabetes Mellitus
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Proportional Hazards Models
  • Survival Rate

Cite this